Global Medical AI 麻豆原创 Research Report 2023

Publication ID:

PB504234061

Publication Date:

May 15, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

The purpose of the study is to enable the reader to gain a holistic view of the global AI in healthcare market, by each of the segments mentioned above.

The report constitutes an in-depth analysis of the global AI in healthcare market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers integrated devices, software, and services related to AI in healthcare.
Highlights
The global Medical AI market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Medical AI is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Medical AI is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Medical AI in Medical Imaging and Diagnosis is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Medical AI include Activ Surgical, Inc., Atomwise, Inc., Babylon Health, BenevolentAI, Butterfly Network, Inc., Freenome, General Electric Company, International Business Machines Corporation (IBM) and Koninklijke Philips N.V., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical AI, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical AI.
The Medical AI market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical AI market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical AI companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Activ Surgical, Inc.
Atomwise, Inc.
Babylon Health
BenevolentAI
Butterfly Network, Inc.
Freenome
General Electric Company
International Business Machines Corporation (IBM)
Koninklijke Philips N.V.
Nuance Communications, Inc.
Nvidia Corporation
Olive
Siemens Healthineers AG
Viz.ai, Inc.
Zebra Medical Vision Ltd
Segment by Type
AI-Integrated Hardware
Software
Services
Segment by Application
Medical Imaging and Diagnosis
Data Management
Telemedicine
Remote Monitoring and Lifestyle Management
Robot-Assisted Surgery
Drug Discover and Clinical Trials
Virtual Assistance
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical AI companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Medical AI 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 AI-Integrated Hardware
1.2.3 Software
1.2.4 Services
1.3 麻豆原创 by Application
1.3.1 Global Medical AI 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical Imaging and Diagnosis
1.3.3 Data Management
1.3.4 Telemedicine
1.3.5 Remote Monitoring and Lifestyle Management
1.3.6 Robot-Assisted Surgery
1.3.7 Drug Discover and Clinical Trials
1.3.8 Virtual Assistance
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical AI 麻豆原创 Perspective (2018-2029)
2.2 Medical AI Growth Trends by Region
2.2.1 Global Medical AI 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medical AI Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Medical AI Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Medical AI 麻豆原创 Dynamics
2.3.1 Medical AI Industry Trends
2.3.2 Medical AI 麻豆原创 Drivers
2.3.3 Medical AI 麻豆原创 Challenges
2.3.4 Medical AI 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical AI Players by Revenue
3.1.1 Global Top Medical AI Players by Revenue (2018-2023)
3.1.2 Global Medical AI Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Medical AI 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical AI Revenue
3.4 Global Medical AI 麻豆原创 Concentration Ratio
3.4.1 Global Medical AI 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical AI Revenue in 2022
3.5 Medical AI Key Players Head office and Area Served
3.6 Key Players Medical AI Product Solution and Service
3.7 Date of Enter into Medical AI 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical AI Breakdown Data by Type
4.1 Global Medical AI Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Medical AI Forecasted 麻豆原创 Size by Type (2024-2029)
5 Medical AI Breakdown Data by Application
5.1 Global Medical AI Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Medical AI Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Medical AI 麻豆原创 Size (2018-2029)
6.2 North America Medical AI 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medical AI 麻豆原创 Size by Country (2018-2023)
6.4 North America Medical AI 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical AI 麻豆原创 Size (2018-2029)
7.2 Europe Medical AI 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medical AI 麻豆原创 Size by Country (2018-2023)
7.4 Europe Medical AI 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical AI 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Medical AI 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medical AI 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Medical AI 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical AI 麻豆原创 Size (2018-2029)
9.2 Latin America Medical AI 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medical AI 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Medical AI 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical AI 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Medical AI 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medical AI 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Medical AI 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Activ Surgical, Inc.
11.1.1 Activ Surgical, Inc. Company Detail
11.1.2 Activ Surgical, Inc. Business Overview
11.1.3 Activ Surgical, Inc. Medical AI Introduction
11.1.4 Activ Surgical, Inc. Revenue in Medical AI Business (2018-2023)
11.1.5 Activ Surgical, Inc. Recent Development
11.2 Atomwise, Inc.
11.2.1 Atomwise, Inc. Company Detail
11.2.2 Atomwise, Inc. Business Overview
11.2.3 Atomwise, Inc. Medical AI Introduction
11.2.4 Atomwise, Inc. Revenue in Medical AI Business (2018-2023)
11.2.5 Atomwise, Inc. Recent Development
11.3 Babylon Health
11.3.1 Babylon Health Company Detail
11.3.2 Babylon Health Business Overview
11.3.3 Babylon Health Medical AI Introduction
11.3.4 Babylon Health Revenue in Medical AI Business (2018-2023)
11.3.5 Babylon Health Recent Development
11.4 BenevolentAI
11.4.1 BenevolentAI Company Detail
11.4.2 BenevolentAI Business Overview
11.4.3 BenevolentAI Medical AI Introduction
11.4.4 BenevolentAI Revenue in Medical AI Business (2018-2023)
11.4.5 BenevolentAI Recent Development
11.5 Butterfly Network, Inc.
11.5.1 Butterfly Network, Inc. Company Detail
11.5.2 Butterfly Network, Inc. Business Overview
11.5.3 Butterfly Network, Inc. Medical AI Introduction
11.5.4 Butterfly Network, Inc. Revenue in Medical AI Business (2018-2023)
11.5.5 Butterfly Network, Inc. Recent Development
11.6 Freenome
11.6.1 Freenome Company Detail
11.6.2 Freenome Business Overview
11.6.3 Freenome Medical AI Introduction
11.6.4 Freenome Revenue in Medical AI Business (2018-2023)
11.6.5 Freenome Recent Development
11.7 General Electric Company
11.7.1 General Electric Company Company Detail
11.7.2 General Electric Company Business Overview
11.7.3 General Electric Company Medical AI Introduction
11.7.4 General Electric Company Revenue in Medical AI Business (2018-2023)
11.7.5 General Electric Company Recent Development
11.8 International Business Machines Corporation (IBM)
11.8.1 International Business Machines Corporation (IBM) Company Detail
11.8.2 International Business Machines Corporation (IBM) Business Overview
11.8.3 International Business Machines Corporation (IBM) Medical AI Introduction
11.8.4 International Business Machines Corporation (IBM) Revenue in Medical AI Business (2018-2023)
11.8.5 International Business Machines Corporation (IBM) Recent Development
11.9 Koninklijke Philips N.V.
11.9.1 Koninklijke Philips N.V. Company Detail
11.9.2 Koninklijke Philips N.V. Business Overview
11.9.3 Koninklijke Philips N.V. Medical AI Introduction
11.9.4 Koninklijke Philips N.V. Revenue in Medical AI Business (2018-2023)
11.9.5 Koninklijke Philips N.V. Recent Development
11.10 Nuance Communications, Inc.
11.10.1 Nuance Communications, Inc. Company Detail
11.10.2 Nuance Communications, Inc. Business Overview
11.10.3 Nuance Communications, Inc. Medical AI Introduction
11.10.4 Nuance Communications, Inc. Revenue in Medical AI Business (2018-2023)
11.10.5 Nuance Communications, Inc. Recent Development
11.11 Nvidia Corporation
11.11.1 Nvidia Corporation Company Detail
11.11.2 Nvidia Corporation Business Overview
11.11.3 Nvidia Corporation Medical AI Introduction
11.11.4 Nvidia Corporation Revenue in Medical AI Business (2018-2023)
11.11.5 Nvidia Corporation Recent Development
11.12 Olive
11.12.1 Olive Company Detail
11.12.2 Olive Business Overview
11.12.3 Olive Medical AI Introduction
11.12.4 Olive Revenue in Medical AI Business (2018-2023)
11.12.5 Olive Recent Development
11.13 Siemens Healthineers AG
11.13.1 Siemens Healthineers AG Company Detail
11.13.2 Siemens Healthineers AG Business Overview
11.13.3 Siemens Healthineers AG Medical AI Introduction
11.13.4 Siemens Healthineers AG Revenue in Medical AI Business (2018-2023)
11.13.5 Siemens Healthineers AG Recent Development
11.14 Viz.ai, Inc.
11.14.1 Viz.ai, Inc. Company Detail
11.14.2 Viz.ai, Inc. Business Overview
11.14.3 Viz.ai, Inc. Medical AI Introduction
11.14.4 Viz.ai, Inc. Revenue in Medical AI Business (2018-2023)
11.14.5 Viz.ai, Inc. Recent Development
11.15 Zebra Medical Vision Ltd
11.15.1 Zebra Medical Vision Ltd Company Detail
11.15.2 Zebra Medical Vision Ltd Business Overview
11.15.3 Zebra Medical Vision Ltd Medical AI Introduction
11.15.4 Zebra Medical Vision Ltd Revenue in Medical AI Business (2018-2023)
11.15.5 Zebra Medical Vision Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Activ Surgical, Inc.
Atomwise, Inc.
Babylon Health
BenevolentAI
Butterfly Network, Inc.
Freenome
General Electric Company
International Business Machines Corporation (IBM)
Koninklijke Philips N.V.
Nuance Communications, Inc.
Nvidia Corporation
Olive
Siemens Healthineers AG
Viz.ai, Inc.
Zebra Medical Vision Ltd

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.